PEPTIDE SURROGATES IN RAPID SYNTHESIS OF HIV PROTEASE INHIBITORS

快速合成 HIV 蛋白酶抑制剂中的肽替代物

• 批准号: 7955262
• 负责人: CHI-HUEY WONG
• 金额: $ 3.89万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-05-01 至 2010-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7955262
• 关键词: Achievement; Amides; Biological; Biomedical Computing; Computer Retrieval of Information on Scientific Projects Database; Development; Funding; Goals; Grant; Institution; Laboratories; Nature; Peptides; Property; Protease Inhibitor; Research; Research Personnel; Resources; Source; United States National Institutes of Health; absorption; combinatorial; drug candidate; improved; inhibitor/antagonist; lipophilicity; novel

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Given the ubiquitous nature of the peptide linkage in biological molecules, replacement of the amide bond with isosteres in potential drug candidates has been a continual goal of many laboratories. Successful replacements will provide improved stability, lipophilicity, and absorption. Many surrogates have been introduced already, yet the synthesis of many of these isosteres in a combinatorial way is difficult and requires several steps. Thus, the discovery of new peptide surrogates with easier syntheses is an important achievement that could open new opportunities for the study of amide-containing molecules and the development of inhibitors with novel physicochemical properties.

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 鉴于生物分子中多肽连接的无处不在的性质，用异构体取代酰胺键 潜在的候选药物一直是许多实验室的持续目标。成功更换将提供更好的 稳定性、亲油性和吸收能力。许多替代品已经被引入，但其中许多的合成 组合方式的同位素体是困难的，需要几个步骤。因此，新的多肽替代物的发现 更容易的合成是一项重要的成就，可能为含酰胺类化合物的研究开辟新的机会 分子和具有新的物理化学性质的缓蚀剂的开发。